Imatinib mesylate in the treatment of systemic mastocytosis - A phase II trial

HJ (Jolanda) Drogendijk; HC Kluin-Nelemans; JJ van Doormaal; Arnold Oranje; AA van de Loosdrecht; Paul van Daele

doi:10.1002/cncr.21996

Imatinib mesylate in the treatment of systemic mastocytosis - A phase II trial

HJ (Jolanda) Drogendijk
, HC Kluin-Nelemans
, JJ van Doormaal
, Arnold Oranje
, AA van de Loosdrecht
, Paul van Daele

Research output: Contribution to journal › Article › Academic › peer-review

149 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	345-351
Number of pages	7
Journal	Cancer
Volume	107
Issue number	2
DOIs	https://doi.org/10.1002/cncr.21996
Publication status	Published - 2006

Research programs

EMC MM-02-72-02
EMC MM-03-61-05-A

Access to Document

10.1002/cncr.21996

http://hdl.handle.net/1765/68187

Cite this

@article{16f1a24f589844eb9462e8e2ec0ce5af,

title = "Imatinib mesylate in the treatment of systemic mastocytosis - A phase II trial",

author = "Drogendijk, \{HJ (Jolanda)\} and HC Kluin-Nelemans and \{van Doormaal\}, JJ and Arnold Oranje and \{van de Loosdrecht\}, AA and \{van Daele\}, Paul",

year = "2006",

doi = "10.1002/cncr.21996",

language = "Undefined/Unknown",

volume = "107",

pages = "345--351",

journal = "Cancer",

issn = "0008-543X",

publisher = "John Wiley \& Sons Inc.",

number = "2",

}

TY - JOUR

T1 - Imatinib mesylate in the treatment of systemic mastocytosis - A phase II trial

AU - Drogendijk, HJ (Jolanda)

AU - Kluin-Nelemans, HC

AU - van Doormaal, JJ

AU - Oranje, Arnold

AU - van de Loosdrecht, AA

AU - van Daele, Paul

PY - 2006

Y1 - 2006

U2 - 10.1002/cncr.21996

DO - 10.1002/cncr.21996

M3 - Article

C2 - 16779792

SN - 0008-543X

VL - 107

SP - 345

EP - 351

JO - Cancer

JF - Cancer

IS - 2

ER -